Old Web
English
Sign In
Acemap
>
Paper
>
P1.18-02 The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC
P1.18-02 The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC
2019
John V. Heymach
J Taube
Tetsuya Mitsudomi
D. Harpole
M Aperghis
L. Trani
M Powell
P. Dennis
Martin Reck
Keywords:
Oncology
General surgery
Adjuvant
Internal medicine
Medicine
Durvalumab
in patient
stage ii
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
12
Citations
NaN
KQI
[]